Philip Mack

10PUBLICATIONS
85CO-AUTHORS
Predictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Molecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 04, 2025
Elevated ctDNA Tumor Fraction Is Associated with Improved Mutation Detection but Worse Overall Survival in Advanced Non-Small Cell Lung Cancer: A Lung-MAP Study.

Philip C Mack, Mary W Redman, Hanna Tukachinsky

|Jul 27, 2024
Time-Dependent Effects of Clinical Interventions on SARS-CoV-2 Immunity in Patients with Lung Cancer.

Philip C Mack, Chih-Yuan Hsu, Ananda M Rodilla

|May 24, 2024
Multi-cancer early detection (MCED) tests: prioritizing equity from bench to bedside.

Sarah J Miller, Jamilia R Sly, Christian Rolfo

|May 26, 2023
Phase II Study of Docetaxel and Trametinib in Patients with KRAS Mutation Positive Recurrent Non-Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042).

Shirish M Gadgeel, Jieling Miao, Jonathan W Riess

|Jun 17, 2022
Circulating Tumor DNA Kinetics Predict Progression-Free and Overall Survival in EGFR TKI-Treated Patients with EGFR-Mutant NSCLC (SWOG S1403).

Philip C Mack, Jieling Miao, Mary W Redman

Pageof 2